These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1721416)

  • 21. Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience.
    Abu-Elmagd K; Todo S; Fung J; Demetris J; Rakela J; Rao AS; Iwatsuki S; Starzl T
    Clin Transpl; 1994; ():133-56. PubMed ID: 7547533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow augmentation of kidney allografts can cause graft-versus-host disease in immunosuppressed recipients.
    Pirenne J; Moon C; Gruessner A; Benedetti E; Nakhleh RE; Uckun F; Gruessner RW
    Transplant Proc; 1996 Apr; 28(2):941-2. PubMed ID: 8623472
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
    Furlong T; Storb R; Anasetti C; Appelbaum FR; Deeg HJ; Doney K; Martin P; Sullivan K; Witherspoon R; Nash RA
    Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus.
    Mookerjee B; Altomonte V; Vogelsang G
    Bone Marrow Transplant; 1999 Sep; 24(5):517-20. PubMed ID: 10482936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.
    Fung J; Abu-Elmagd K; Jain A; Gordon R; Tzakis A; Todo S; Takaya S; Alessiani M; Demetris A; Bronster O
    Transplant Proc; 1991 Dec; 23(6):2977-83. PubMed ID: 1721333
    [No Abstract]   [Full Text] [Related]  

  • 26. Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients.
    Choi CJ; Nghiem P
    Arch Dermatol; 2001 Sep; 137(9):1202-6. PubMed ID: 11559218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical experience with FK 506].
    Starzl TE; Abu-Elmagd K; Fung JJ; Todo S; Tzakis AG; McCauley J; Demetris AJ
    Presse Med; 1991 Nov; 20(40):1967-73. PubMed ID: 1722311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.
    Fay JW; Wingard JR; Antin JH; Collins RH; Piñeiro LA; Blazar BR; Saral R; Bierer BE; Przepiorka D; Fitzsimmons WE; Maher RM; Weisdorf DJ
    Blood; 1996 Apr; 87(8):3514-9. PubMed ID: 8605372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tacrolimus ointment in the treatment of chronic cutaneous graft-versus-host disease].
    Firmin D; Karam A; Guillerm G; Roguedas AM; Berthou C; Misery L
    Ann Dermatol Venereol; 2008 Mar; 135(3):234-6. PubMed ID: 18374862
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.
    Nash RA; Antin JH; Karanes C; Fay JW; Avalos BR; Yeager AM; Przepiorka D; Davies S; Petersen FB; Bartels P; Buell D; Fitzsimmons W; Anasetti C; Storb R; Ratanatharathorn V
    Blood; 2000 Sep; 96(6):2062-8. PubMed ID: 10979948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report.
    Sánchez AR; Sheridan PJ; Rogers RS
    J Periodontol; 2004 Apr; 75(4):613-9. PubMed ID: 15152828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrolimus with mini-methotrexate as prophylaxis for graft-versus-host disease in pediatric patients after allogeneic peripheral blood stem cell transplant or bone marrow transplant.
    Sabapathy C; Gourde JA; Khan SP; Rodriguez V
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):945-9. PubMed ID: 19131788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
    Devine SM; Geller RB; Lin LB; Dix SP; Holland HK; Maurer D; O'Toole K; Keller J; Connaghan DG; Heffner LT; Hillyer CD; Rodey GE; Winton EF; Maher RM; Fitzsimmons WE; Wingard JR
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):25-33. PubMed ID: 9209738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FK 506 versus cyclosporine in pediatric liver transplantation.
    Tzakis AG; Reyes J; Todo S; Green M; Ohya T; Jain A; Abu-Elmagd K; Alessiani M; Fung JJ; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3010-5. PubMed ID: 1721343
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclosporine-induced graft vs host disease in two patients receiving syngeneic bone marrow transplants.
    Dale BM; Atkinson K; Kotasek D; Biggs JC; Sage RE
    Transplant Proc; 1989 Oct; 21(5):3816-7. PubMed ID: 2815290
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prophylaxis with FK-506 for graft-versus-host disease after transplantation of bone marrow from unrelated donors].
    Hamazaki T; Yagi K; Inoue M; Sakata N; Okamura T; Yasui M; Sasabe M; Kishimoto T; Inoue A; Kawa K
    Rinsho Ketsueki; 2000 May; 41(5):430-6. PubMed ID: 10879106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of cyclosporine for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
    Gluckman E; Devergie A; Lokiec F
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):461-9. PubMed ID: 3291282
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion.
    Murase N; Ye Q; Lee RG; Demetris AJ; Abu-Elmagd K; Reyes J; Starzl TE
    Transplant Proc; 1999; 31(1-2):565-6. PubMed ID: 10083238
    [No Abstract]   [Full Text] [Related]  

  • 40. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.
    Luznik L; O'Donnell PV; Symons HJ; Chen AR; Leffell MS; Zahurak M; Gooley TA; Piantadosi S; Kaup M; Ambinder RF; Huff CA; Matsui W; Bolaños-Meade J; Borrello I; Powell JD; Harrington E; Warnock S; Flowers M; Brodsky RA; Sandmaier BM; Storb RF; Jones RJ; Fuchs EJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):641-50. PubMed ID: 18489989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.